Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) EPS (Basic) (2016 - 2025)

Cryo Cell International (CCEL) has disclosed EPS (Basic) for 16 consecutive years, with -$0.47 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 104.35% to -$0.47 in Q4 2025 year-over-year; TTM through Nov 2025 was -$0.3, a 700.0% decrease, with the full-year FY2025 number at -$0.3, down 700.0% from a year prior.
  • EPS (Basic) was -$0.47 for Q4 2025 at Cryo Cell International, down from $0.09 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.15 in Q2 2021 to a low of -$1.34 in Q4 2023.
  • A 5-year average of -$0.04 and a median of $0.08 in 2022 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): soared 225.0% in 2022, then tumbled 1440.0% in 2023.
  • Cryo Cell International's EPS (Basic) stood at -$0.08 in 2021, then skyrocketed by 225.0% to $0.1 in 2022, then crashed by 1440.0% to -$1.34 in 2023, then surged by 82.84% to -$0.23 in 2024, then tumbled by 104.35% to -$0.47 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's EPS (Basic) are -$0.47 (Q4 2025), $0.09 (Q3 2025), and $0.05 (Q2 2025).